For the latest updates on Gilead’s ongoing response to COVID-19, please click here.

Find a Treatment Center

Investor Relations

Contact Us

KiteKonnect®

Newsroom

Recent Press Releases

May 17, 2022
Gilead and Kite Oncology to Highlight Advances Supporting New Innovations in Cancer Care at the ASCO Annual Meeting
April 19, 2022
Kite Receives U.S. FDA Approval of New State-of-the-Art CAR T-Cell Therapy Manufacturing Facility in Maryland

Recent Company Statements

February 9, 2021
Kite Announces U.S. FDA Clearance of Investigational New Drug Application for KITE-222, an Anti-CLL-1 CAR T-Cell Therapy Candidate for Acute Myeloid Leukemia

Explore More

Media Inquiries

Gilead Newsroom